CCF (inc pulmonary oedema) Flashcards

1
Q

What is heart failure?

A

Clinical syndrome resulting from almost any cardiac disorder that impairs ability of ventricle to fill with or eject blood.
i.e. CO less than body needs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is forward heart failure?

A

Heart unable to maintain adequate CO to meet demand, or can only do so by elevating filling pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is backward heart failure?

A

Heart unable to accommodate venous return resulting in elevated filling pressure and vascular congestion (systemic or pulmonary).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs and symptoms of low CO LHF?

A
  • Fatigue
  • Syncope
  • Systemic hypotension
  • Cool extremities
  • Slow capillary refill
  • Peripheral cyanosis
  • Pulsus alternans
  • Mitral regurgitation
  • S3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs and symptoms of backward (venous congestion) LHF?

A
  • Dyspnoea, orthopnoea, PND
  • Cough
  • Crackles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Signs and symptoms of forward RHF?

A
  • LHF symptoms if RHF leads to LV underfilling
  • Tricuspid regurgitation
  • S3 (rhs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Signs and symptoms of backward RHF?

A
  • Peripheral oedema
  • Pulsatile liver (if TR)
  • Hepatosplenomegaly
  • elevated JVP w/ abdominal jugular reflex and Kussmaul’s sign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline the pathophysiology of heart failure.

A

Compensatory vascular and cardiac changes to maintain CO. As HF progressives, mechanisms overhwelmed: peripheral vasoconstriction and Na+ retention due to RAAS activation (decompensation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the systemic response in heart failure?

A

SNS activation. Systemic response to ineffective circulating volume:

  • RAAS activation (retain H20 and Na)
  • increased HR and contractility
  • increased afterload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is systolic dysfunction?

A

Impaired myocardial contractile function -> decreased LVEF and SV -> decreased CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs systolic dysfunction?

A
  • Displaced apex beat
  • S3
  • increased heart size on CXR
  • Decreased LVEF
  • LV dilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes LV systolic dysfunction?

A
  • Ischaemic: e.g. CAD, MI

- Non-ischaemic: HTN, DM, alcohol/toxins, myocarditis, dilated cardiomyopathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is heart failure with preserved ejection fraction also known as?

A

Diastolic dysfunction!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference b/w systolic dysfunction and HFPEF?

A

Up to 50% HF pts have normal systolic fxn i.e. preserved ejection fraction; heart failure caused by impaired diastolic filling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pathophysiology of HFPEF?

A

Impaired diastolic filling -> increased LV filling pressures -> upstream venous congestion (pulmonary, systemic).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Signs HFPEF?

A
  • Apex beat sustained
  • S4
  • Normal heart size on CXR
  • HTN
  • LVH on ECG/Echo
  • Normal LVEF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Causes of decreased compliance in HFPEF?

A

-Transient: ischaemia
-Permanent:
>severe hypertrophy (HTN, AS, HCM)
>restrictive cardiomyopathy (e.g. amyloid)
>MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe NYHA heart failure classification.

A

i: ordinary physical activity does not cause symptoms.
ii: comfortable at rest, ordinary activity causes symptoms
iii: limitation of ordinary activity, less than ordinary physical activity causes symptoms
iv: inability to carry out any physical activity without discomfort; symptoms may be present at rest.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is high output heart failure?

A

Demand for increased CO; often exacerbates existing HF of decompensates pt w/ other cardiac pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ddx high output heart failure?

A
  • Anemia
  • Thyrotoxicosis
  • Thiamine deficiency
  • A-V fistula / L>R shunting
  • Paget’s disease
  • Renal Disease
  • Hepatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Precipitants of heart failure?

A

HEART FAILED

  • HTN
  • Endocrine (phaechromocytoma / hyperaldosteronism)
  • Anemia
  • RHD / other valvular disease
  • Thyrotoxicosis
  • Failure to take Rx
  • Arrhythmia
  • Infection / ischaemia / infarction
  • Lung (PE / pneumonia / COPD)
  • Endocarditis / environment
  • Dietary (e.g. FR non compliance)
22
Q

Blood Ix heart failure?

A
  • FBE
  • UEC
  • CMP
  • fasting BSL
  • HbA1C
  • Lipids
  • LFTs
  • TSH
  • Iron studies
  • BNP
23
Q

ECG features to look for in heart failure?

A
  • Chamber enlargement
  • Arrhythmia
  • Ischaemia / infarction
24
Q

CXR features to look for in heart failure?

A

HERB-B

  • Heart enlargement
  • Effusion (pleural)
  • Re-distribution (alveolar oedema)
  • B Lines (Kerley B lines)
  • Bronchiolar-alveolar cuffing
25
Q

Echo features in heart failure?

A
  • LVEF
  • Cardiac dimensions
  • Wall motion abnormalities
  • Valvular disease
  • Pericardial effusion
26
Q

What is the acute treatment of heart failure?

A

Treat precipitants! +

  • L) Lasix: frusemide 40 - 500mg IV
  • M) Morphine: 2-4mg IV
  • N) Nitroglycerin: topical / IV/ SL
  • O) Oxygen: in hypoxemic patients
  • P) Position/positive airway pressure (CPAP/BiPAP)
27
Q

Why is morphine given in acute treatment heart failure?

A

Decreases anxiety and preload.

28
Q

Conservative measures for symptomatic management of HF?

A

Oxygen in hospital, bed rest, elevate head of bed.

29
Q

Lifestyle measures for conservative management of heart failure?

A
  • Diet / exercise
  • Smoking cessation
  • DM control
  • Decrease EtOH
  • Patient education
  • FR and Na restriction
30
Q

Pharmacological management of heart failure?

A

1) Vasodilators (ACEi / ARB)
2) B-blocker
3) Diuretics
4) Aldosterone antagonist
5) Inotropes
6) Antiarrhythmics
7) Anticoagulants

31
Q

In which pts should ACEi be instituted?

A
  • All symptomatic pts class II-IV

- Asymptomatic pts LVEF

32
Q

When should ARB be instituted?

A
  • Second line to ACEi if not tolerated; adjunct to ACEi if B-blockers not tolerated
  • Consider in acute renal failure until creatinine stabilises
33
Q

Which pts should receive B-blocker therapy?

A

-Class I - III with LVEF

34
Q

Which pts should receive spironolactone?

A

Class IIIb and IV CHF already on ACEi and loop diuretic.

35
Q

Indications for inotropes in heart failure?

A
  • Patient in sinus rhythm and symptomatic on ACEi,

- or CHF + AF

36
Q

When should biventricular pacemaker be considered?

A
  • QRS>130msec

- LVEF

37
Q

What are the pathophysiological changes in heart failure?

A
  • Ventricular dilation
  • Myocyte hypertrophy
  • Increased collagen synthesis
  • Increased ANP secretion
  • Na+ and water retention
  • SNS activation
  • Peripheral vasoconstriction
38
Q

What is after load?

A

Outflow Resistance (afterload): load the heart pumps against = pulmonary/systemic resistance + physical characteristics of vessel walls + volume of blood ejected.

39
Q

Effect of neurohormonal activation in HF?

A
  • SNS activated by baroreceptors early in HF, provides inotropic support to maintain CO.
  • Chronic SNS ==> increases neurhormonal activation + myocyte apoptosis —> B-receptor downregulation.
40
Q

What are the major Framingham criteria for HF? (dx = 1 major, 2 minor)

A

Major (SAWPANIC)
◦S3 heart sound present (‘gallop’ sound)
◦Acute pulmonary oedema (left side of heart is unable to clear fluid from lungs)
◦Weight loss of more than 4.5kg in 5 days when treated (patients lose retained fluids)
◦Paroxysmal nocturnal dyspnoea
◦Abdominojugular reflux (JVP waveform rises when pressure applied over liver area)
◦Neck vein distended (i.e. JVP elevated at rest)
◦Increased cardiac shadow on X-ray (cardiomegaly: heart occupies more than ≈50% of chest diameter)
◦Crackles heard in lungs

41
Q

What are the minor Framingham criteria for HF?

A

MINOR (HEARTV)

  • Hepatomegaly
  • Effusion, pleural
  • Ankle oedema bilaterally
  • exeRtional dyspnoea
  • Tachycardia
  • Vital capacity decreased by 1/3 max value
42
Q

What are Starling Forces across capillaries?

A

Fluid leaks in/out according to balance of forces (hydrostatic, oncotic).
Tends out at arterial; in at venous.

43
Q

In relation to Starling Forces at Capillaries, alteration at which end causes pulmonary oedema?

A

Fluid tends out at arterial; in at venous.

Increases in VENOUS pressure causes fluid to leak out and oedema.

44
Q

What are the causes of oedema?

A
  • Increased venous pressure e.g. HF
  • Decreased osmotic pressure e.g. plasma protein loss (hep/ren failure)
  • Blockage of lymphatics e.g. cancer
  • Increased capillary permeability e.g. infection
45
Q

Alterations in pressure in which vessels cause oedema?

A

VENOUS not arterial.

46
Q

What is indicated by elevated JVP?

A

High RA pressure (therefore high RVED pressure).

Generally also thus high LA (&LVED) pressure.

47
Q

Causes of pure RHF?

A
  • PAH: Cor pulmonale e.g. COPD / CF; PE
  • Right structural disease: pul or tricuspid valves; R ventricular cardiomyopathy
  • Pericardial disease
48
Q

What are the 4 key components of pt diagnosis of HF?

A

1) Is it HF?
2) What is underlying cause?
3) Precipitating cause of this episode?
4) What other problems? (i.e. CV/ Renal / hepatic)

49
Q

Principles of HF treatment?

A
  • Reduce venous pressure
  • Block RAAS
  • Blocks SNS (B blocker)
  • Treat underlying and precipitating causes
50
Q

Which B-blocker should be used in patients with asthma?

A

Metoprolol: B1 selective therefore better for asthma / COPD patients.